glutathione synthetase inhibitor Frontiers Inhibition of the glutathione biosynthetic
Description
doi: 10.1038/nm1477
In 2023, the Alzheimer disease segment took the lead in the global market, securing 60% of the total revenue share
Ling SM, Kaplan SA, Weitzman JJ, Reed GB, Costin G, Landing BH
Conflict of interest The authors declare no conflict of interests
Our peptide therapy can also improve sleep quality, fatigue, depression, anxiety, and mental focus
